SCS Capital Management LLC Trims Stock Holdings in HCA Healthcare, Inc. $HCA

SCS Capital Management LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 11.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 60,182 shares of the company’s stock after selling 7,821 shares during the quarter. SCS Capital Management LLC’s holdings in HCA Healthcare were worth $28,096,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Nordea Investment Management AB raised its stake in shares of HCA Healthcare by 11.2% during the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after purchasing an additional 108,849 shares during the last quarter. Savant Capital LLC raised its stake in shares of HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares during the last quarter. Hudson Bay Capital Management LP raised its stake in shares of HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after purchasing an additional 2,849 shares during the last quarter. Advisors Capital Management LLC grew its holdings in HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC grew its holdings in HCA Healthcare by 1,062.4% during the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after acquiring an additional 8,733 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of recent analyst reports. Sanford C. Bernstein dropped their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. Barclays dropped their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. TD Cowen lowered their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Mizuho upped their target price on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Finally, Oppenheimer lowered their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Stock Down 0.2%

HCA opened at $377.72 on Monday. The firm has a market cap of $83.79 billion, a P/E ratio of 12.99, a PEG ratio of 1.20 and a beta of 1.12. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The business’s fifty day simple moving average is $451.94 and its 200 day simple moving average is $480.89.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.